Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55,574,229
-
Total 13F shares
-
28,774,674
-
Share change
-
+5,505,227
-
Total reported value
-
$1,040,063,755
-
Price per share
-
$36.25
-
Number of holders
-
59
-
Value change
-
+$201,305,468
-
Number of buys
-
48
-
Number of sells
-
8
Institutional Holders of Ascendis Pharma A/S - ADR (ASND) as of Q3 2017
As of 30 Sep 2017,
Ascendis Pharma A/S - ADR (ASND) was held by
59 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,774,674 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, LLC, FMR LLC, ORBIMED ADVISORS LLC, BAKER BROS. ADVISORS LP, EcoR1 Capital, LLC, Vivo Capital, LLC, venBio Select Advisor LLC, VHCP Management II, LLC, EVENTIDE ASSET MANAGEMENT, LLC, and DEERFIELD MANAGEMENT CO.
This page lists
59
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.